Clinical Trial

Non-invasive Central Venous Pressure Estimation in Pediatric Patients

Study acronym: CPMX-CVP-Ped
Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated September 18, 2025 (before its estimated March 31, 2026 completion). Its status may not reflect the trial's current state.
Summary
Central Venous Pressure (CVP) is a standard parameter for hemodynamic monitoring and is currently measured through the insertion of a catheter. The pediatric population is especially vulnerable to risks associated to this invasive procedure, including infection, thrombosis, and pneumothorax. The proposed pilot study will evaluate safety and preliminary efficacy of a new non-invasive ultrasound-based venous occlusion pressure (VOP) monitoring device (CPMX2) in children equipped with an invasive catheter for CVP monitoring as part of standard of care.
Protocol Amendment History 2 amendments
This ClinicalTrials.gov record has been amended 2 times since 2025-03-12; most recent amendment 2025-09-12.
Status change: Not Yet Recruiting → Recruiting 2025-08-25
Trial Details
NCT Number NCT06885073
Lead Sponsor Compremium AG
Conditions Central Venous Pressure
Enrollment 100 participants
Start Date 2025-03-10
Primary Completion 2026-03-31 (estimated)
Study Completion 2026-03-31 (estimated)
Updated on ClinicalTrials.gov 2025-09-18